Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2003 1
2004 1
2005 3
2006 1
2007 2
2010 1
2011 2
2015 1
2016 4
2017 5
2018 9
2019 4
2020 8
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Results by year
Filters applied: . Clear all
Page 1
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.
Brouwer PJM, Caniels TG, van der Straten K, Snitselaar JL, Aldon Y, Bangaru S, Torres JL, Okba NMA, Claireaux M, Kerster G, Bentlage AEH, van Haaren MM, Guerra D, Burger JA, Schermer EE, Verheul KD, van der Velde N, van der Kooi A, van Schooten J, van Breemen MJ, Bijl TPL, Sliepen K, Aartse A, Derking R, Bontjer I, Kootstra NA, Wiersinga WJ, Vidarsson G, Haagmans BL, Ward AB, de Bree GJ, Sanders RW, van Gils MJ. Brouwer PJM, et al. Among authors: de bree gj. Science. 2020 Aug 7;369(6504):643-650. doi: 10.1126/science.abc5902. Epub 2020 Jun 15. Science. 2020. PMID: 32540902 Free PMC article.
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study.
Schurink B, Roos E, Radonic T, Barbe E, Bouman CSC, de Boer HH, de Bree GJ, Bulle EB, Aronica EM, Florquin S, Fronczek J, Heunks LMA, de Jong MD, Guo L, du Long R, Lutter R, Molenaar PCG, Neefjes-Borst EA, Niessen HWM, van Noesel CJM, Roelofs JJTH, Snijder EJ, Soer EC, Verheij J, Vlaar APJ, Vos W, van der Wel NN, van der Wal AC, van der Valk P, Bugiani M. Schurink B, et al. Among authors: de bree gj. Lancet Microbe. 2020 Nov;1(7):e290-e299. doi: 10.1016/S2666-5247(20)30144-0. Epub 2020 Sep 25. Lancet Microbe. 2020. PMID: 33015653 Free PMC article.
Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.
Tuijnenburg P, Lango Allen H, Burns SO, Greene D, Jansen MH, Staples E, Stephens J, Carss KJ, Biasci D, Baxendale H, Thomas M, Chandra A, Kiani-Alikhan S, Longhurst HJ, Seneviratne SL, Oksenhendler E, Simeoni I, de Bree GJ, Tool ATJ, van Leeuwen EMM, Ebberink EHTM, Meijer AB, Tuna S, Whitehorn D, Brown M, Turro E, Thrasher AJ, Smith KGC, Thaventhiran JE, Kuijpers TW; NIHR BioResource–Rare Diseases Consortium. Tuijnenburg P, et al. Among authors: de bree gj. J Allergy Clin Immunol. 2018 Oct;142(4):1285-1296. doi: 10.1016/j.jaci.2018.01.039. Epub 2018 Mar 2. J Allergy Clin Immunol. 2018. PMID: 29477724 Free PMC article.
Is reaching 90-90-90 enough to end AIDS? Lessons from Amsterdam.
de Bree GJ, van Sighem A, Zuilhof W, van Bergen JEAM, Prins M, Heidenrijk M, van der Valk M, Brokx P, Reiss P; HIV Transmission Elimination AMsterdam (H-TEAM) Initiative. de Bree GJ, et al. Curr Opin HIV AIDS. 2019 Nov;14(6):455-463. doi: 10.1097/COH.0000000000000586. Curr Opin HIV AIDS. 2019. PMID: 31589173 Review.
[HIV vaccine: how far along are we?].
Reiss EIMM, van Gils MJ, Sanders RW, de Bree GJ. Reiss EIMM, et al. Among authors: de bree gj. Ned Tijdschr Geneeskd. 2020 Sep 3;164:D5167. Ned Tijdschr Geneeskd. 2020. PMID: 33030332 Dutch.
B cells in HIV pathogenesis.
de Bree GJ, Lynch RM. de Bree GJ, et al. Curr Opin Infect Dis. 2016 Feb;29(1):23-30. doi: 10.1097/QCO.0000000000000225. Curr Opin Infect Dis. 2016. PMID: 26658653 Review.
53 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page